Abiopharma

MannKind Reports First Quarter 2026 Financial Results and Provides Business Update

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer

Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Fluor to Participate in Upcoming Investor Conferences

Palantir Joins U.S. Army and Industry Partners for “Right to Integrate” Hackathon Sprint for Defense-wide Interoperability

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xencor Reports First Quarter 2026 Financial Results

Symbotic Reports Second Quarter Fiscal Year 2026 Results